The PE Ratio as of December 2024 (TTM) for NeuroPace, Inc. (NPCE) is -11.67

According to NeuroPace, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -11.67. This represents a change of 21.51% compared to the average of -9.60 of the last 4 quarters.

NeuroPace, Inc. (NPCE) Historical PE Ratio (quarterly & annually)

How has NPCE PE Ratio performed in the past?

The mean historical PE Ratio of NeuroPace, Inc. over the last ten years is -9.27. The current -11.67 PE Ratio has changed 12.48% with respect to the historical average. Over the past ten years (40 quarters), NPCE's PE Ratio was at its highest in in the December 2022 quarter at -0.74. The PE Ratio was at its lowest in in the September 2020 quarter at -16.79.

NeuroPace, Inc. (NPCE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of NeuroPace, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeuroPace, Inc. (NPCE) Average PE Ratio

How has NPCE PE Ratio performed in the past?

The current PE Ratio of NeuroPace, Inc. (NPCE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NeuroPace, Inc. (NPCE) PE Ratio vs. Peers

How is NPCE’s PE Ratio compared to its peers?

NeuroPace, Inc.’s PE Ratio is less than Electromed, Inc. (37.93), greater than OrthoPediatrics Corp. (-18.43), greater than Surmodics, Inc. (-48.58), greater than Paragon 28, Inc. (-13.84), less than Nevro Corp. (-2.03), less than NuVasive, Inc. (56.43), less than Integer Holdings Corporation (39.62), greater than Glaukos Corporation (-54.59), less than CONMED Corporation (16.20), less than ProSomnus, Inc. (-0.59), less than Anika Therapeutics, Inc. (-2.46), greater than Heska Corporation (-67.36), less than Pulmonx Corporation (-4.31), less than IRadimed Corporation (36.78), less than Orthofix Medical Inc. (-5.60), less than CVRx, Inc. (-4.87), greater than Artivion, Inc. (-1397.11),

Build a custom stock screener for NeuroPace, Inc. (NPCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroPace, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroPace, Inc. (NPCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroPace, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.